The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 4 of 1566 for:    partner 3 trial

Zambia One Love Aim 3 Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02744586
Recruitment Status : Completed
First Posted : April 20, 2016
Last Update Posted : February 1, 2018
Sponsor:
Information provided by (Responsible Party):
Susan Allen, Emory University

Brief Summary:
The aim of this study is to determine whether a Strengthening our Vows (SOV) intervention will reduce HIV exposures from concurrent partnership (CP) when compared to the control Good Health Package Plus (GHPP), in addition to couples' voluntary HIV counseling and testing (CVCT), among concordant HIV-negative couples living in Zambia.

Condition or disease Intervention/treatment Phase
HIV Sexually Transmitted Diseases Neglected Diseases Non-communicable Diseases Behavioral: Strengthening Our Vows (SOV) Behavioral: Good Health Package Plus (GHPP) Not Applicable

Detailed Description:

This is a randomized control study to evaluate novel interventions to reduce risk factors associated with HIV, neglected tropical and non-communicable diseases among couples in Zambia.

The aim of this study is to determine whether a Strengthening our Vows (SOV) intervention will reduce HIV exposures from concurrent partnership (CP) when compared to the control Good Health Package Plus (GHPP), in addition to couples' voluntary HIV counseling and testing (CVCT), among concordant HIV-negative couples.

Investigators seeks to compare the impact of the SOV intervention and the GHPP intervention on reduction in a composite of risk factors associated with HIV acquisition from concurrent partners, compare the impact of GHPP and SOV on knowledge and use of hygiene and sanitation measures and hypertension and diabetes screening and management, and compare self-reported couples' testing (CVCT) with outside partners in the SOV and GHPP arms.

Couples will receive SOV or GHPP based on the pre-randomization of the clinic which they attend for standard of care HIV counseling and testing. The Strengthening our Vows (SOV) intervention will seek to establish a dialogue or norm where couples will be able to protect each other from HIV infection from outside partners. The Good Health Package Plus (GHPP) intervention focuses on strategies to improve household health related to diarrheal diseases, helminths, schistosomiasis, diabetes, and hypertension.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 3450 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: A Randomized Control Study to Evaluate Novel Interventions to Reduce Risk Factors Associated With HIV, Neglected Tropical and Non-communicable Diseases Among Couples in Zambia
Study Start Date : January 2016
Actual Primary Completion Date : December 2016
Actual Study Completion Date : December 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV

Arm Intervention/treatment
Experimental: Strengthening our Vows (SOV) Group
Participants in the SOV arm will participate in the "Together HIV Free" and "Protecting My Spouse" plans.
Behavioral: Strengthening Our Vows (SOV)

Participants, led by a counselor, will discuss options to keep HIV from entering their relationship including both sex partners remaining monogamous, using condoms every time they have sex with outside partners, and being tested together with outside partners to ensure they are HIV negative (Together HIV Free Plan). Participants will discuss options in the event of an outside exposure to HIV including abstaining from having sex with their spouse or by using condoms every time they have sex with their spouse until they can be retested for HIV after 30 days (Protecting my Spouse Plan).

Participants will be screened for hypertension, diabetes, schistosomiasis, HIV, syphilis, and trichomonas vaginalis and the presence of sperm (women only). Health problems will be treated or referred. Couples will be administered questionnaires that record self-report of sexually transmitted infections, number of outside partners, and reports of sex without a condom with outside partners.


Placebo Comparator: Good Health Package Plus (GHPP) Group
Participants in the GHPP arm will receive education on the prevention of helminths, schistosomiasis, hypertension, diabetes, and diarrheal diseases through participatory and interactive group sessions.
Behavioral: Good Health Package Plus (GHPP)
Participants, led by a counselor, will discuss how to prevent, screen, and treat neglected tropical diseases (helminths and schistosomiasis), non-communicable diseases (hypertension and diabetes) and diarrheal diseases through basic hygiene and sanitation. The facilitator will demonstrate proper handwashing techniques and chlorination of water and discuss diet and lifestyle changes. Participants will be screened for hypertension, diabetes, schistosomiasis, HIV, syphilis, and trichomonas vaginalis and the presence of sperm (women only). Health problems will be treated or referred. Couples will also be administered questionnaires that record self-report of sexually transmitted infections, number of outside partners, and reports of sex without a condom with outside partners.




Primary Outcome Measures :
  1. HIV Incidence Rate [ Time Frame: Duration of Study (Up to six months) ]
    The number of new laboratory confirmed HIV diagnosis.

  2. Syphilis Incidence Rate [ Time Frame: Duration of Study (Up to six months) ]
    The number of new laboratory confirmed syphilis diagnosis.

  3. Vaginal Trichomoniasis Incidence Rate [ Time Frame: Duration of Study (Up to six months) ]
    The number of new laboratory confirmed vaginal trichomoniasis diagnosis.

  4. Number of Self-Reported Sexually Transmitted Infections (STIs) [ Time Frame: Duration of Study (Up to six months) ]
    The number of self-reported STIs via questionnaire.

  5. Number of Reports of Sex without a Condom with Outside Partners [ Time Frame: Duration of Study (Up to six months) ]
    The number of reports of sex without using a condom reported via a study specific questionnaire.

  6. Number of Reported Outside Partners [ Time Frame: Duration of Study (Up to six months) ]
    The self-reported number of sexual partners outside of marriage.

  7. Knowledge and use of hygiene and sanitation measures [ Time Frame: Duration of Study (Up to six months) ]
    Number of participants who show increased knowledge of hygiene and sanitation measures via a study specific questionnaire.

  8. Knowledge of hypertension and diabetes screening and management [ Time Frame: Duration of Study (Up to six months) ]
    Number of participants who show increased knowledge of hypertension and diabetes screening and management via a study specific questionnaire.

  9. Number of self-reports of accessing couples' testing (CVCT) with outside partners [ Time Frame: Duration of Study (Up to six months) ]
    Number of participants who report accessing CVCT services with their outside partners reported via a study specific questionnaire.


Secondary Outcome Measures :
  1. Perceived Efficacy of Chlorine Use [ Time Frame: Duration of Study (Up to six months) ]
    The number of participants who report a perceived effect of chlorine use via a study specific questionnaire.

  2. Perceived Efficacy of Handwashing [ Time Frame: Duration of Study (Up to six months) ]
    The number of participants who report a perceived effect of handwashing via a study specific questionnaire.

  3. Perceived Efficacy of Deworming [ Time Frame: Duration of Study (Up to six months) ]
    The number of participants who report a perceived effect of deworming via a study specific questionnaire.

  4. Perceived Efficacy of Management of Diabetes [ Time Frame: Duration of Study (Up to six months) ]
    The number of participants who report a perceived effect of management of diabetes via a study specific questionnaire.

  5. Perceived Efficacy of Management of Hypertension [ Time Frame: Duration of Study (Up to six months) ]
    The number of participants who report a perceived effect of management of hypertension via a study specific questionnaire.

  6. Change in Communication between Husband and Wife [ Time Frame: Duration of Study (Up to six months) ]
    Change in communication between husband and wife dyads regarding exposure to HIV through extramarital sexual behaviors will be measured using a study specific questionnaire.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

Heterosexual Zambian couples who have undergone CVCT as standard of care in government health clinics in Lusaka and Ndola. Couples must be women 18-45 cohabiting with men 18-65 years old, have cohabited 3 months or greater, are both HIV-negative and are able to attend the scheduled follow-up visits.

  • Heterosexual HIV-concordant negative
  • Cohabiting at least 3 months
  • Both partners at least 18 years of age (women aged 18-45, men aged 18-65)
  • Not on antiretroviral therapy including Post Exposure Prophylaxis (PEP) or Pre Exposure Prophylaxis (PrEP)
  • Interested in participating
  • Able and willing to provide informed consent (literacy is not required)
  • Willing to complete interviewer-administered questionnaires on risk factors
  • Available for follow-up for the duration of the study
  • Willing and able to be contacted via phone or home visit
  • Able and willing to provide adequate locator/contact information for retention purposes, and willing to be contacted by the study staff

Exclusion Criteria:

  • Presence of any condition that, in the opinion of the investigator or designee, would preclude provision of informed consent, or otherwise interfere with achieving the study objectives
  • Either partner HIV-positive or with indeterminate HIV rapid test results
  • Attendance to a clinic involved in the opposite arm of the study (i.e., test with partner at a clinic indicated as SOV but attends a clinic indicated as GHPP or vice versa)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02744586


Locations
Layout table for location information
Zambia
Ndola Research Site
Ndola, Copperbelt, Zambia
Lusaka Research Site
Lusaka, Zambia
Sponsors and Collaborators
Emory University
Investigators
Layout table for investigator information
Principal Investigator: Susan Allen, MD, MPH Emory University
Layout table for additonal information
Responsible Party: Susan Allen, Professor, Emory University
ClinicalTrials.gov Identifier: NCT02744586    
Other Study ID Numbers: IRB00083001
First Posted: April 20, 2016    Key Record Dates
Last Update Posted: February 1, 2018
Last Verified: January 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by Susan Allen, Emory University:
Sexually transmitted infections
Neglected tropical diseases
Non-communicable diseases
Additional relevant MeSH terms:
Layout table for MeSH terms
Sexually Transmitted Diseases
Noncommunicable Diseases
Neglected Diseases
Communicable Diseases
Infections
Genital Diseases
Urogenital Diseases
Disease Attributes
Pathologic Processes